Medication info
Super Dia Tablet 500mg (Metformin Hydrochloride)

Super Dia Tablet 500mg (Metformin Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Anguk Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
500 tablets/bottle
Approval status
Active

MFDS item code 201905811 · Approved 2019.08.16 · Insurance code 650205800

Summary

Main use
Treatment of type 2 diabetes mellitus
Who uses it
Adults · Children
Adult dosage
The dose should be determined individually based on efficacy and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and determine the minimum dose needed for adequate glycemic control, this medicine must be started at a low dose, and 500mg should be taken 2~3 times daily with meals. Increase the dose gradually by 500mg each week; when the dose is up to 2000mg, it is usually divided into 2 doses per day, taken in the morning and evening. If the dose exceeds 2000mg, divide it into 3 doses per day and take with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, fasting blood glucose should be measured to assess the response to this medicine and determine the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. The treatment goal for this medicine, when administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose glucose was controlled by diet alone, a short course of treatment with this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate (stage 3a) renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine should be discontinued immediately.
Children's dosage
Pediatric patients aged 10 years and older or adolescents during growth: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 administrations.

Ingredients

Manufacturer
Anguk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Patients with type 2 diabetes who do not have sufficient blood sugar control
View approved original text

This medication is used in adult patients with type 2 diabetes who have difficulty controlling blood sugar levels through diet and exercise alone, especially those who are overweight. Adults can take it alone or in combination with other oral hypoglycemic agents or insulin. It can also be used in children aged 10 and older as monotherapy or in combination with insulin, making it suitable for a variety of patient groups. This medication effectively helps control blood sugar levels to manage diabetes.

Dosage and Administration

Adult dosage

The dose should be determined individually based on efficacy and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and determine the minimum dose needed for adequate glycemic control, this medicine must be started at a low dose, and 500mg should be taken 2~3 times daily with meals. Increase the dose gradually by 500mg each week; when the dose is up to 2000mg, it is usually divided into 2 doses per day, taken in the morning and evening. If the dose exceeds 2000mg, divide it into 3 doses per day and take with meals; the maximum daily dose is 2550mg. At initiation of treatment and during dose adjustment, fasting blood glucose should be measured to assess the response to this medicine and determine the minimum effective dose. Glycated hemoglobin levels should be measured approximately every 3 months. The treatment goal for this medicine, when administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose glucose was controlled by diet alone, a short course of treatment with this medicine may be sufficient to achieve an adequate effect. This medicine may be used in patients with moderate (stage 3a) renal impairment (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, administered in 2 divided doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate decreases below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine should be discontinued immediately.

Children's dosage

Pediatric patients aged 10 years and older or adolescents during growth: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. This dose should be divided into 2~3 administrations.

Precautions

This medication can cause serious side effects such as severe lactic acidosis or hypoglycemia, so caution is required. It should not be used in patients with moderate to severe renal impairment, dehydration, severe infections, or cardiovascular problems. It should also be avoided in patients with acute heart failure, those scheduled for tests using radiological iodine contrast agents, and those allergic to this medication or similar drugs. Patients with specific forms of diabetes, severe infections, pre- or post-surgery, malnutrition, or liver dysfunction should also use this medication with caution. It can cause a rare but serious side effect called lactic acidosis; patients should immediately inform healthcare professionals if symptoms such as muscle pain, shortness of breath, weakness, or abdominal pain occur. Gastrointestinal symptoms may commonly occur but are usually temporary; if symptoms are severe, dosage adjustments or changes in administration may be needed. Renal function should be monitored regularly, particularly in elderly patients or those with decreased renal function. This medication may interact with other drugs; if other medications are being taken, inform the physician or pharmacist. During pregnancy, there may be fetal effects, so consultation with a specialist is necessary for those who are pregnant or planning to become pregnant. If breastfeeding, careful consideration is needed as this medication can be excreted in breast milk, affecting the decision to continue or stop breastfeeding. Special caution is needed in children and elderly patients, particularly in the case of children, where administration should follow a doctor's instructions. Overdose may require treatments like hemodialysis, so seek immediate medical attention. Regular blood glucose testing and renal function monitoring are important during treatment. Additionally, alcohol consumption should be avoided during use, as it may increase the risk of lactic acidosis. This medication does not cause weight gain, which can be advantageous for diabetic patients needing weight management. Finally, store this medication out of reach of children and do not transfer it to another container.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • anorexia
  • indigestion
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver function abnormalities
  • severe delayed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture from entering, and it is recommended to store it at room temperature between 1 and 30 degrees Celsius. This will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.